Market Overview

Teleflex Introduces Innovative Technology for Lung Isolation Procedures

Related TFX
What's In Store For Athenahealth's Q2 Earnings?
Benzinga's Top Upgrades, Downgrades For March 7, 2017
Stocks To Watch With Earnings Approaching: Teleflex (Investor's Business Daily)

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced today its Rusch^® EZ-Blocker^™ Disposable Endobronchial Blocker has received 510(k) clearance. The addition of the EZ-Blocker Endobronchial Blocker to the Teleflex Airway Management portfolio enhances the company's product offerings, which include clinically differentiated Rusch and Sheridan^® brands of endotracheal and endobronchial products.

Posted-In: News FDA


Related Articles (TFX)

View Comments and Join the Discussion!